A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma
Primary Sponsor
Melanoma and Skin Cancer Trials Limited (MASC Trials)
Collaborating Groups
TROG Cancer Research
Participating Centres
Current Accrual
Trial Chairperson
Dr Wen Xu, Princess Alexandra Hospital, QLD
Related Post
August 2, 2022
Celebrating and bringing radiation medicine research to the forefront at our 2022 ASM
After a hiatus from in-person events due to COVID-19
February 28, 2022
Cancer trial participant hoping to help
The RAVES trial treating prostate cancer Participating in a
